Phytoestrogen supplementation: A case report of male breast cancer

European Journal of Cancer Prevention

Volumn 13, Issue 6, 2004, Pages 481-484

  Dimitrakakis, C ^a,c   Gosselink, L ^a   Gaki, V ^b   Bredakis, N ^b   Keramopoulos, A ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b IASO   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; Male; Phytoestrogens

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PHYTOESTROGEN;

ADULT; ANAMNESIS; ARTICLE; BREAST CARCINOMA; CASE REPORT; ECHOGRAPHY; HOSPITAL ADMISSION; HUMAN; MALE; MAMMOGRAPHY; ONCOGENE; PRIORITY JOURNAL;

BREAST NEOPLASMS, MALE; DIET; DIETARY SUPPLEMENTS; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PHYTOESTROGENS;

EID: 10244229639     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200412000-00003     Document Type: Article

References (20)

1. Amato P, Christophe S, Mellon PL (2002). Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9: 145-150.
2. Dimitrakakis C, Zhou J, Bondy CA (2002). Androgens and mammary growth and neoplasia. Fertil Steril 77(Suppl 4): S26-S33.
3. Dimitrakakis C, Zhou J, Wang J, et al. (2003). A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10: 292-298.
4. Fugh-Berman A (2003). 'Bust enhancing' herbal products. Obstet Gynecol 101: 1345-1349.
5. Hargreaves DF, Potten CS, Harding C, et al. (1999). Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 84: 4017-4024.
6. Hsieh CY, Santell RC, Haslam SZ, et al. (1998). Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833-3838.
7. Johnson EB, Muto MG, Yanushpolsky EH, et al. (2001). Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol 98(Pt 2): 947-50.
8. Knight DC, Eden JA (1996). A review of the clinical effects of phytoestrogens. Obstet Gynecol 87(Pt 2): 897-904.
9. Kurzer MS (2003). Phytoestrogen supplement use by women. J Nutr 133: 1983S-1986S.
10. Kurzer MS, Xu X (1997). Dietary phytoestrogens. Annu Rev Nutr 17: 353-381.
11. Messina MJ, Loprinzi CL (2001). Soy for breast cancer survivors: a critical review of the literature. J Nutr 131(Suppl 11): 3095S-3108S.
12. Mills PK, Beeson WL, Phillips RL, et al. (1989). Dietary habits and breast cancer incidence among Seventh-day Adventists. Cancer 64: 582-590.
13. Mishra SI, Dickerson V, Najm W (2003). Phytoestrogens and breast cancer prevention: what is the evidence? Am J Obstet Gynecol 188(5 Suppl): S66-S70.
14. Peeters PH, Keinan-Boker L, van der Schouw YT, et al. (2003). Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77: 171-183.
15. Petrakis NL, Barnes S, King EB, et al. (1996). Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5: 785-794.
16. Pino AM, Valladares LE, Palma MA, et al. (2000). Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Cln Endocrinol Metab 85: 2797-2800.
17. Pumford SL, Morton MM, Turkes A, et al. (2002). Determination of the isoflavonoids genistein and daidzein in biological samples by gas chromatography-mass spectrometry. Annu Clin Biochem 39(Pt 3): 281-292.
18. Ramanathan L, Gray WG (2003). Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell. Toxicol Appl Pharmacol 191: 107-117.
19. Willett W (2003). Lessons from dietary studies in Adventists and questions for the future. Am J Clin Nutr 78(Suppl 3): 539S-543S.
20. Zava DT, Duwe G (1997). Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40.